OSE Immunotherapeutics benefits from an international network that offers access to the best experts in immunotherapy and transplantation, due to historic academic relationships.
Partnerships in basic research are currently conducted:
- In Europe with the European Center for Sciences in Transplantation and Immunotherapy (CESTI) (which brings together the clinical teams of the University Hospital Institute and the teams of the INSERM Center for Research in Transplantation and Immunology – CRTI – INSERM 1UMR064), the Regional University Hospital and the University of Nantes, other French CNRS or INSERM teams, the « Children’s Cancer Research Institute » of Vienna (Austria), the “Biomedical Primate Research Center” in Netherlands and the Oxford University,
- In the U.S. with the Maryland University in Baltimore and the « Ben Towne Center for Childhood Cancer Research » in Seattle (Washington).
This international network of excellence has resulted in promising data having been published in key scientific publications, resulting in increased visibility of the company’s achievements (Poirier et al. Science Translational Médicine 2010).
OSE Immunotherapeutics is supported by major institutional organizations : Pays de la Loire Territoires d’Innovation, Atlanpole Biothérapies, Bpifrance, and by national funding : « Prime d’aménagement du territoire », a funding for regional development.